6505--Metoprolol Tartrate Tablets

SOL #: 36E79725R0071Solicitation

Overview

Buyer

Veterans Affairs

Veterans Affairs, Department Of

NAC PHARMACEUTICALS (36E797)

HINES, IL, 60141, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Original Source

https://sam.gov/opp/5a112bc3088b43f5b3df31d4d9cbea55/view

Timeline

Posted

Oct 9, 2025

Last Updated

Feb 4, 2026

Submission Deadline

Nov 18, 2025, 8:30 PM

Qualification Details

Fit reasons

NAICS alignment with historical contract wins in similar service areas.
Scope strongly matches core technical capabilities and delivery model.

Risks

Past performance thresholds may require one additional teaming partner.
Potential clarification needed on staffing minimums before bid/no-bid.

Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), National Acquisition Center, is soliciting proposals for Metoprolol Tartrate IR Tablets to establish a supply source for VA and DoD Pharmaceutical Prime Vendor Programs. This is an Unrestricted acquisition. Offers are due November 21, 2025, at 2:30 PM Central Time.

Scope of Work

The procurement aims to secure Metoprolol Tartrate Tablets in various strengths and package sizes (100, 500, 1000 tablets per bottle) for nationwide usage. Key requirements include:

Providing an 11-digit National Drug Code (NDC) unique to the company for each drug.
Products must meet FDA standards and cGMP requirements.
Bar code labeling conforming to GS1-128 or HIBCC standards.
Compliance with Drug Supply Chain Security Act (DSCSA) requirements.
Packaging with safety caps (for bottles of 400 tablets or less) and compatibility with automated dispensing units.

Contract Details

Type: Firm Fixed Price, Indefinite-Delivery Requirements contract.
Period of Performance: A base ordering period of one year (effective 5/8/2026 - 5/7/2027), with four one-year option periods, for a total potential duration of five years.
Set-Aside: Unrestricted acquisition.
Product Service Code (PSC): 6505 (Drugs And Biologicals).
NAICS Code: 325412.

Submission & Evaluation

Offer Due Date: November 21, 2025, at 2:30 PM Central Time.
Submission Method: Offers must be submitted via email in Microsoft Word or PDF format, including a scanned copy of the signed SF-1449.
Pricing: Proposals must include pricing for the base year and all four option years for all specified line items, and incorporate a 0.5% Cost Recovery Fee.
Evaluation: Award will be based on the Lowest Price Technically Acceptable (LPTA) offer. Technical acceptability requires meeting product descriptions, unique NDC numbers, FDA approval, FDA cGMP compliance, and manufacturing facility clearance.
Eligibility: Offerors not manufacturing the items must submit a Letter of Commitment from the manufacturer. Other than small business concerns may be required to submit a subcontracting plan for contracts over $750,000.